Angiogenesis Publications
Becker, C. M., R. D. Wright, et al. (2006). "A Novel Noninvasive Model of Endometriosis for Monitoring the
Efficacy of Antiangiogenic Therapy." Am J Pathol 168(6): 2074-2084.
Bjorndahl, M. A., R. Cao, et al. (2005). "Vascular Endothelial Growth Factor-A Promotes Peritumoral
Lymphangiogenesis and Lymphatic Metastasis." Cancer Res 65(20): 9261-9268.
Cai, W. and X. Chen (2007). "Multimodality imaging of vascular endothelial growth factor and vascular
endothelial growth factor receptor expression." Front Biosci 12: 4267-79.
Casarez, E. V., M. E. Dunlap-Brown, et al. (2007). "Radiosensitization and modulation of p44/42 mitogenactivated protein kinase by 2-Methoxyestradiol in prostate cancer models." Cancer Res 67(17): 831624.
Cheng, D., C. Lo, et al. (2008). "Effect of mouse VEGF(164) on the viability of hydroxyethyl methacrylatemethyl methacrylate-microencapsulated cells in vivo: Bioluminescence imaging." J Biomed Mater Res A.
Dickson, P. V., J. B. Hamner, et al. (2007). "Continuous delivery of IFN-beta promotes sustained maturation
of intratumoral vasculature." Mol Cancer Res 5(6): 531-42.
Ehrbar, M., S. M. Zeisberger, et al. (2007). "The role of actively released fibrin-conjugated VEGF for VEGF
receptor 2 gene activation and the enhancement of angiogenesis." Biomaterials.
Faley, S. L., K. Takahashi, et al. (2007). "Bioluminescence imaging of vascular endothelial growth factor
promoter activity in murine mammary tumorigenesis." Mol Imaging 6(5): 331-9.
Hamner, J. B., P. V. Dickson, et al. (2007). "Bortezomib inhibits angiogenesis and reduces tumor burden in
a murine model of neuroblastoma." Surgery 142(2): 185-91.
Harada, H., S. Kizaka-Kondoh, et al. (2007). "Significance of HIF-1-active cells in angiogenesis and
radioresistance." Oncogene.
He, Y., I. Rajantie, et al. (2005). "Vascular Endothelial Cell Growth Factor Receptor 3-Mediated Activation of
Lymphatic Endothelium Is Crucial for Tumor Cell Entry and Spread via Lymphatic Vessels." Cancer Res
65(11): 4739-4746.
Hsu, A. R., W. Cai, et al. (2007). "Multimodality molecular imaging of glioblastoma growth inhibition with
vasculature-targeting fusion toxin VEGF121/rGel." J Nucl Med 48(3): 445-54.
Kunnumakkara, A. B., S. Guha, et al. (2007). "Curcumin potentiates antitumor activity of gemcitabine in an
orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition
of nuclear factor-kappaB-regulated gene products." Cancer Res 67(8): 3853-61.
Lin, J., A. S. Lalani, et al. (2005). "Inhibition of Lymphogenous Metastasis Using Adeno-Associated VirusMediated Gene Transfer of a Soluble VEGFR-3 Decoy Receptor." Cancer Res 65(15): 6901-6909.
Mi, J., S. Sarraf-Yazdi, et al. (2006). "A Comparison of Antiangiogenic Therapies for the Prevention of Liver
Metastases." Journal of Surgical Research In Press, Corrected Proof.
Nguyen Huu, S., M. Oster, et al. (2007). "Maternal neoangiogenesis during pregnancy partly derives from
fetal endothelial progenitor cells." Proc Natl Acad Sci U S A 104(6): 1871-6.
Ohlfest, J. R., Z. L. Demorest, et al. (2005). "Combinatorial Antiangiogenic Gene Therapy by Nonviral Gene
Transfer Using the Sleeping Beauty Transposon Causes Tumor Regression and Improves Survival in
Mice Bearing Intracranial Human Glioblastoma." Molecular Therapy 12(5): 778-788.
Ou-Yang, F., K.-L. Lan, et al. (2006). "Endostatin-Cytosine Deaminase Fusion Protein Suppresses Tumor
Growth by Targeting Neovascular Endothelial Cells." Cancer Res 66(1): 378-384.
Ramos, O. H., A. Kauskot, et al. (2007). "A novel alpha(v)beta (3)-blocking disintegrin containing the RGD
motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis." Clin Exp Metastasis.
Rapisarda, A., J. Zalek, et al. (2004). "Schedule-dependent Inhibition of Hypoxia-inducible Factor-1{alpha}
Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma
Xenografts." Cancer Res 64(19): 6845-6848.
Ryan, P. L., R. C. Youngblood, et al. (2005). "Photonic Monitoring in Real Time of Vascular Endothelial
Growth Factor Receptor 2 Gene Expression under Relaxin-Induced Conditions in a Novel Murine Wound
Model." Ann NY Acad Sci 1041(1): 398-414.
Sarraf-Yazdi, S., J. Mi, et al. (2007). "Inhibition of In Vivo Tumor Angiogenesis and Growth Via Systemic
Delivery of an Angiopoietin 2-specific RNA Aptamer." J Surg Res.
Silvertown, J. D., J. Ng, et al. (2005). "H2 relaxin overexpression increases in vivo prostate xenograft tumor
growth and angiogenesis." International Journal of Cancer 9999(9999): NA.
Szentirmai O, Baker CH, et al. (2006). "Noninvasive bioluminescence imaging of luciferase expressing
intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume
and longitudinal use in assessing tumor growth and antiangiogenic treatment effect." Neurosurgery
58(2): 365-72.
Tang, Y., M. Kim, et al. (2005). "In vivo Assessment of RAS-Dependent Maintenance of Tumor Angiogenesis
by Real-time Magnetic Resonance Imaging." Cancer Res 65(18): 8324-8330.
Verheul, H. M., H. Hammers, et al. (2007). "Vascular endothelial growth factor trap blocks tumor growth,
metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model." Clin
Cancer Res 13(14): 4201-8.
Zhang, G. J., T. B. Chen, et al. (2007). "Optical imaging of tumor cells in hollow fibers: evaluation of the
antitumor activities of anticancer drugs and target validation." Neoplasia 9(8): 652-61.
Zhang, N., Z. Fang, et al. (2004). "Tracking angiogenesis induced by skin wounding and contact
hypersensitivity using a Vegfr2-luciferase transgenic mouse." Blood 103(2): 617-26.